IEG Vu is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By


Joseph Harvey

As Editor of Animal Pharm, Joseph Harvey provides news and analysis about the global animal health market across a range of species and products. He conducts exclusive interviews with the sector's biggest companies and experts, as well as start-up firms. He also hosts webinars and gives speeches on the industry.

Having gained many years' experience in business journalism, Joseph joined Informa in 2007, reporting on the medical technology space. He joined Animal Pharm, rising to become editor and taking the publication online only.

Joseph also launched a series of well-received webinars. As author of a top-selling industry report, he detailed the leading companies in the animal health sector. Since becoming editor, he has transformed Animal Pharm from just a news provider into a more in-depth analytical service.
Set Alert for Articles By Joseph Harvey

Latest From Joseph Harvey

Aquabyte reels in $10m series A for machine learning technology

San Francisco-based Aquabyte will speed up development of its computer vision and machine learning software after securing $10 million in funding.

Aquaculture Equipment & Technology

MS Biotec adds animal health industry expertise to management team

Kansas-based MS Biotec has added animal health industry experience by making Sean O'Hare its director of marketing.


Chinese government casts doubt over potential ASF vaccine

Claims by a Chinese company that it is partnering to commercialize a vaccine for African swine fever (ASF) have been rejected by the country's Ministry of Agriculture and Rural Affairs (MARA).

China Hogs & Pork

FDA increases payments to support MUMS innovation

The US FDA has raised its individual funding threshold for minor uses/minor species (MUMS) R&D to $250,000. 

FDA Investments

Fabian Kausche lends R&D expertise in new role as Stonehaven Incubate chairperson

Stonehaven Incubate has added over 25 years of experience in the animal health sector by making Fabian Kausche its new chairperson. 

People Operations

PetIQ claims its animal health focus can revitalize Perrigo

US pet medication developer and distributor PetIQ believes it can help recent acquisition Perrigo Animal Health return to annual growth. 

M&A Operations
See All